{'fraction_non_alphanumeric': 0.02264808362369338, 'fraction_numerical': 0.0, 'mean_word_length': 5.318681318681318, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The case for a fair compensation policy of economic consequences incurred by living kidney donors.

Living-donor kidney transplantation (LDKTx) yields the best results of all renal replacement therapies (RRT) in terms of patient survival, but remains frequently underused in many countries. Reasons for this unsatisfactory situation are multifold, among which is the possibly overlooked or underestimated negative financial and/or economic consequences to the donors. This topic is addressed in a comprehensive review by Clarke et al. presented in this issue of the Journal.